Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2026 | 04-2025 | 04-2024 | 04-2023 | 04-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,837,000 | 4,691,000 | 3,705,000 | 3,784,000 | 5,062,000 |
| Depreciation Amortization | 2,958,000 | 2,861,000 | 2,647,000 | 2,697,000 | 2,707,000 |
| Income taxes - deferred | 51,000 | -316,000 | -508,000 | -226,000 | -604,000 |
| Accounts receivable | -200,000 | -433,000 | -391,000 | -576,000 | -477,000 |
| Other Working Capital | -1,423,000 | -1,054,000 | -484,000 | -967,000 | -889,000 |
| Other Operating Activity | 1,107,000 | 1,295,000 | 1,818,000 | 1,327,000 | 1,547,000 |
| Operating Cash Flow | $7,330,000 | $7,044,000 | $6,787,000 | $6,039,000 | $7,346,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -620,000 | 269,000 | -307,000 | -171,000 | -190,000 |
| PPE Investments | -1,904,000 | -1,859,000 | -1,587,000 | -1,459,000 | -1,368,000 |
| Net Acquisitions | -406,000 | -98,000 | -211,000 | -1,867,000 | -91,000 |
| Other Investing Activity | -4,000 | -249,000 | -261,000 | 4,000 | -10,000 |
| Investing Cash Flow | $-2,934,000 | $-1,937,000 | $-2,366,000 | $-3,493,000 | $-1,659,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 9,000 | -1,070,000 | 1,073,000 | 2,284,000 | N/A |
| Debt Issued | 1,747,000 | 3,209,000 | N/A | 5,409,000 | N/A |
| Debt Repayment | -2,930,000 | N/A | N/A | -6,012,000 | -1,000 |
| Common Stock Issued | 1,054,000 | 508,000 | 284,000 | 308,000 | 429,000 |
| Common Stock Repurchased | -1,035,000 | -3,235,000 | -2,138,000 | -645,000 | -2,544,000 |
| Dividend Paid | -3,639,000 | -3,589,000 | -3,666,000 | -3,616,000 | -3,383,000 |
| Other Financing Activity | 43,000 | -184,000 | -3,000 | -2,688,000 | 163,000 |
| Financing Cash Flow | $-4,751,000 | $-4,361,000 | $-4,450,000 | $-4,960,000 | $-5,336,000 |
| Exchange Rate Effect | 85,000 | 188,000 | -230,000 | 243,000 | -231,000 |
| Beginning Cash Position | 2,218,000 | 1,284,000 | 1,543,000 | 3,714,000 | 3,593,000 |
| End Cash Position | 1,949,000 | 2,218,000 | 1,284,000 | 1,543,000 | 3,714,000 |
| Net Cash Flow | $-269,000 | $934,000 | $-259,000 | $-2,171,000 | $121,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,330,000 | 7,044,000 | 6,787,000 | 6,039,000 | 7,346,000 |
| Capital Expenditure | -1,904,000 | -1,859,000 | -1,587,000 | -1,459,000 | -1,368,000 |
| Free Cash Flow | 5,426,000 | 5,185,000 | 5,200,000 | 4,580,000 | 5,978,000 |